Work

Abstract PS2-06-12: Quantifying the Minimum Acceptable Benefit for a Novel Oral Adjuvant Therapy in HR+/HER2− Early Breast Cancer: A Probabilistic Threshold Technique Study in Italy

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps2-06-12

Authors: A. Zambelli, R. Berardi, B. Canali, R. Mercati, A. Messi, M. Suter, I. Viganò, D. Valsecchi, G. Arpino

Institutions: Ospedale Papa Giovanni XXIII, Marche Polytechnic University, Novartis (Italy), Federico II University Hospital, University of Naples Federico II

Language: English

Topic: Health Systems, Economic Evaluations, Quality of Life

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129267571

Cites:

Cited by:

Related to: